Asthma severity in four countries of Latin America
- PMID: 31288777
- PMCID: PMC6617663
- DOI: 10.1186/s12890-019-0871-1
Asthma severity in four countries of Latin America
Abstract
Background: In Latin America, there is scarce information about severe asthma (SA) according to the ERS/ATS 2014 criteria. This study aimed to compare the demographic, socio, clinical characteristics, treatment, and use of healthcare resources between SA and non-severe asthma (NSA) patients in Argentina, Colombia, Chile and Mexico.
Methods: A cross-sectional study was conducted including 594 asthma patients from outpatient specialized sites. A descriptive analysis was performed comparing SA patients and NSA. Chi-square and Mann Whitney tests were used to assess associations between asthma severity and outcome variables.
Results: Using ERS/ATS 2014 criteria, 31.0% of the patients were identified as SA. SA patients were older at diagnosis (mean age 31.64 years vs 24.71 years, p < 0.001) and had higher proportion of uncontrolled asthma than the NSA patients (64.1% vs 53.2%, p < 0.001). SA patients reported a significantly higher proportion of both hospital admission and emergency room (ER) visits due to asthma in the last year, compared with NSA patients, 8.7% vs. 3.7% (p = 0.011) and 37.0% vs. 21.7% (p < 0.001), respectively.
Conclusions: SA patients were older, had greater proportions in some comorbidities and experienced increased healthcare utilization. Also, our results showed that even in patients using the last steps of treatment (GINA step 4 or 5), there was still a higher proportion of uncontrolled disease.
Keywords: Asthma; Disease management; Epidemiology; Latin America; Severity.
Conflict of interest statement
HN has nothing to disclosure; KV and FM are GSK employees; CV and GA are GSK complementary employees. CS, GL and VDB are GSK employees and holds GSK stocks.
Figures
Similar articles
-
Key factors associated with uncontrolled asthma - the Asthma Control in Latin America Study.J Asthma. 2020 Feb;57(2):113-122. doi: 10.1080/02770903.2018.1553050. Epub 2019 Mar 27. J Asthma. 2020. PMID: 30915868
-
Patient perspectives of the influence of severe and non-severe asthma on their quality of life: A national survey of asthma patients in Spain.Clin Respir J. 2022 Feb;16(2):130-141. doi: 10.1111/crj.13461. Epub 2021 Nov 17. Clin Respir J. 2022. PMID: 34766442 Free PMC article.
-
The study of severe asthma in Latin America and Spain (1994-2004): characteristics of patients hospitalized with acute severe asthma.J Bras Pneumol. 2009 Jul;35(7):635-44. doi: 10.1590/s1806-37132009000700004. J Bras Pneumol. 2009. PMID: 19669001 English, Portuguese.
-
[Asthma in France: a review of descriptive epidemiological data].Rev Mal Respir. 2010 Feb;27(2):151-9. doi: 10.1016/j.rmr.2009.09.001. Epub 2010 Feb 8. Rev Mal Respir. 2010. PMID: 20206063 Review. French.
-
[Prevalence of asthma in Latin America. Critical look at ISAAC and other studies].Rev Alerg Mex. 2017 Apr-Jun;64(2):188-197. doi: 10.29262/ram.v64i2.256. Rev Alerg Mex. 2017. PMID: 28658727 Review. Spanish.
Cited by
-
Asthma in the Americas: An Update: A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and American Thoracic Society.Ann Am Thorac Soc. 2022 Apr;19(4):525-535. doi: 10.1513/AnnalsATS.202109-1068CME. Ann Am Thorac Soc. 2022. PMID: 35030062 Free PMC article. Review.
-
A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort.J Asthma Allergy. 2022 Aug 26;15:1167-1178. doi: 10.2147/JAA.S365009. eCollection 2022. J Asthma Allergy. 2022. PMID: 36051434 Free PMC article.
-
Prevalence of pulmonary hypertension in children with obstructive sleep apnea living at high altitude.Sleep Med X. 2024 Feb 2;7:100106. doi: 10.1016/j.sleepx.2024.100106. eCollection 2024 Dec. Sleep Med X. 2024. PMID: 38356659 Free PMC article.
-
Breaking the vicious circle-the Asthma Referral Identifier (ReferID) tool.NPJ Prim Care Respir Med. 2022 Oct 8;32(1):40. doi: 10.1038/s41533-022-00296-6. NPJ Prim Care Respir Med. 2022. PMID: 36209272 Free PMC article. Review.
-
Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST).Adv Ther. 2024 Nov;41(11):4008-4031. doi: 10.1007/s12325-024-02967-x. Epub 2024 Aug 31. Adv Ther. 2024. PMID: 39215767 Free PMC article.
References
-
- Sullivan PW, Campbell JD, Ghushchyan VH, Globe G, Lange J, Woolley JM. Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation. J Asthma. 2015;52(7):669–680. doi: 10.3109/02770903.2015.1004683. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical